Skip to content

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

CIK 0001419051

← back to feed
Revenue (TTM)
$87.22K
−52.1% YoY Q3 Nov 2024
Net Income (TTM)
−$2.58M
+43.1% YoY Q3 Nov 2024
EPS Diluted (TTM)
$0.00
Q3 Nov 2024
Gross Margin
70.6%
Q3 Nov 2024
Operating Margin
-4,006.3%
Q3 Nov 2024
Net Margin
-2,963.6%
Q3 Nov 2024
Free Cash Flow (TTM)
−$1.07M
Q3 Nov 2024
Cash
$9.23K
Q3 Nov 2024
Total Debt
$956.97K
Q3 Nov 2024
Shares Outstanding
5.12B sh
Q3 Nov 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings